Association between a genetic variant of the alpha-7 nicotinic acetylcholine receptor subunit and four types of dementia

Dementia and Geriatric Cognitive Disorders

Volumn 28, Issue 1, 2009, Pages 56-62

  Fehér, Ágnes ^a   Juhász, Anna ^a   Rimanóczy, Ágnes ^a   Csibri, Éva ^b   Kálmán, János ^a   Janka, Zoltán ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

7 nicotinic acetylcholine receptor; Alzheimer's disease; Apolipoprotein E; Dementia with Lewy bodies; Pick's disease; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E; BUNGAROTOXIN RECEPTOR;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN; DEMENTIA; DEMENTIA, VASCULAR; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HUMANS; HUNGARY; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; PICK DISEASE OF THE BRAIN; POLYMORPHISM, GENETIC; RECEPTORS, NICOTINIC; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67651208215     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000230036     Document Type: Article

References (32)

1. Selkoe DJ: Alzheimer's disease: genes, proteins and therapy. Physiol Rev 2001;81:741-766. (Pubitemid 32267077)
2. Neef D, Walling AD: Dementia with Lewy bodies: an emerging disease. Am Fam Physician 2006;73:1223-1230.
3. Frederick J: Pick disease - a brief overview. Arch Pathol Lab Med 2006;130:1063-1066.
4. Lund and Manchester Research Groups: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418. (Pubitemid 24118135)
5. Black SE: Therapeutic issues in vascular dementia: studies, designs and approaches. Can J Neurol Sci 2007;34:125-130.
6. Weiland S, Bertrand D, Leonard S: Neuronal nicotinic acetylcholine receptors: from the gene to the disease. Behav Brain Res 2000;113:43-56. (Pubitemid 30645542)
7. 1-42 binds to α7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 2000;275:5626-5632.
8. 1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci 2001;21:RC120:1-5.
9. Wang HY, Li W, Benedetti NJ: α7 nicotinic acetylcholine receptors mediate β-amyloid peptide-induced tau protein phosphorylation. J Biol Chem 2003;278:31547-31553. (Pubitemid 37048332)
10. Gault J, Robinson M, Berger R, Drebing C, Logel J, Hopkins J, Moore T, Jacobs S, Meriwether J, Choi MJ, Kim EJ, Walton K, Buiting K, Davis A, Breese C, Freedman R, Leonard S: Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics 1998;52:173-185. (Pubitemid 28465664)
11. Riley B, Williamson M, Collier D, Wilkie H, Makoff A: A 3-Mb map of a large segmental duplication overlapping the α-7-nicotinic acetylcholine receptor gene (CHRNA7) at human 15q13-q14. Genomics 2002;79:197-209. (Pubitemid 34124023)
12. Flomen RH, Davies AF, Di Forti M, La Cascia C, Mackie-Ogilvie C, Murray R, Makoff AJ: The copy number variant involving part of the alpha7 nicotinic receptor gene contains a polymorphic inversion. Eur J Hum Genet 2008;16:1364-1371.
13. Cedazo-Mínguez C, Cowburn RF: Apolipoprotein E: a major piece in the Alzheimer's disease puzzle. J Cell Mol Med 2001;5:254-266. (Pubitemid 33773001)
14. Mahley RW, Weisgraber KH, Huang Y: Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA 2006;103:5644-5651.
15. Borroni B, Grassi M, Costanzi C, Archetti S, Caimi L, Padovani A: APOE genotype and cholesterol levels in Lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk. Am J Geriatr Psychiatry 2006;14:1022-1031. (Pubitemid 44936994)
16. Kálmán J, Juhász A, Majtényi K, Rimanóczy A, Jakab K, Gárdián G, RaskóI, Janka Z: Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease. Neurobiol Aging 2000;21:555-558. (Pubitemid 30621494)
17. Liou YJ, Lai IC, Hong CJ, Liu HC, Liu TY, Tsai SJ: Association analysis of the partially duplicated alpha7 nicotinic acetylcholine receptor genetic variant and Alzheimer's disease. Dement Geriatr Cogn Disord 2001;12:301-304.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944. (Pubitemid 14076461)
19. McKeith IG: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 2006;9:417-423.
20. McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brian JT, Neill D: Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000;54:1050-1058. (Pubitemid 30151844)
21. World Health Organisation (WHO): The neurological adaptation of the International Classification of Diseases (ICD-10NA). Geneva, World Health Organisation, 1991.
22. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
23. Kálmán J, Juhász A, Császár A, Kanka A, Maglóczky E, Bencsik K, Janka Z, RaskóI: Apolipoprotein E allele frequencies in patients with late-onset sporadic Alzheimer's dementia in Hungary. Acta Neurol Scand 1997;95:56-59. (Pubitemid 27094783)
24. Lai IC, Hong CJ, Tsai SJ: Association study of nicotinic-receptor variants and major depressive disorder. J Affect Disord 2001;66:79-82. (Pubitemid 32787049)
25. Leonard S, Freedman R: Genetics of chromosome 15q13-q14 in schizophrenia. Biol Psychiatry 2006;60:115-122.
26. Kálmán J, Juhász A, Császár A, Kanka A, Rimanóczy A, Janka Z, RaskóI: Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population. Acta Neurol Scand 1998;98:166-168. (Pubitemid 28435309)
27. Janka Z, Juhász A, Rimanóczy Á, Boda K, Márki-Zay J, Kálmán J: Codon 311 (Cys → Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias. Mol Psychiatry 2002;7:110-112. (Pubitemid 34087889)
28. Juhász A, Palotás A, Janka Z, Rimanóczy Á, Palotás M, Bódi N, Boda K, Zana M, Vincze G, Kálmán J: ApoE-491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia. Neurochem Res 2005;30:591-596.
29. Baum L., Lam LC, Kwok T, Lee J, Chiu HF, Mok VC, Wong A, Chen X, Cheung WS, Pang CP, Ma SL, Tang NL, Wong KS, Ng HK: Apolipoprotein E epsilon4 allele is associated with vascular dementia. Dement Geriatr Cogn Disord 2006;22:301-305. (Pubitemid 44651443)
30. Murrell JR, Price B, Lane KA, Baiyewu O, Gureje O, Ogunniyi A, Unverzagt FW, Smith-Gamble V, Gao S, Hendrie HC, Hall KS: Association of apolipoprotein E genotype and Alzheimer disease in African Americans. Arch Neurol 2006;63:431-434.
31. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J: Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 1994;57:1414-1416. (Pubitemid 24342312)
32. Huang HM, Kuo YM, Ou HC, Lin CC, Chuo LJ: Apolipoprotein E polymorphism in various dementias in Taiwan Chinese population. J Neural Transm 2002;109:1415-1421.